Mymovesmatter mobile application for Parkinson's (NCT06582212)
Link hormones with motor fluctuations
- Trial ID
- NCT06582212
- Official Title
- Enabling Women with Parkinson's Disease to Identify and Better Manage Hormonal Triggers
- Goal
- Link hormones with motor fluctuations
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- University Hospital, Grenoble
- Study Type
- INTERVENTIONAL
- Enrollment
- 100 participants
- Conditions
- Digital Technology, Mobile Application, Motor Fluctuations, Oestrogen, Parkinson Disease
- Interventions
- Mymovesmatter mobile application
Summary For Families
The trial is helping women with Parkinson's see whether hormonal changes are linked to motor fluctuations, so they can better predict and manage symptom ups and downs. Participants use the Mymovesmatter mobile app to track menstrual cycles, hormonal treatments like OCP or IUD, and daily motor symptoms, and the app looks for patterns that could inform timing of levodopa or other treatment and lifestyle discussions with clinicians; the app itself does not change medications. It's enrolling non-menopausal women aged 18 to 56 with Parkinson's diagnosed at least two years ago who are on a stable PD medication regimen and able to give informed consent; post-menopausal women and those with conditions preventing safe participation are excluded.
Locations
- CHU Grenoble Alpes, Grenoble, Grenoble, France
- CHU Nantes Hôpital Laennec, Nantes, France
- CHU Rennes -Site Pontchaillou, Rennes, France
- Chu Toulouse, Toulouse, France
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Mymovesmatter mobile application. The trial is helping women with Parkinson's see whether hormonal changes are linked to motor fluctuations, so they can better predict and manage symptom ups and downs. Participants use the Mymovesmatter mobile app to track menstrual cycles, hormonal treatments like OCP or IUD, and daily motor symptoms, and the app looks for patterns that could inform timing of levodopa or other treatment and lifestyle discussions with clinicians; the app itself does not change medications. It's enrolling non-menopausal women aged 18 to 56 with Parkinson's diagnosed at least two years ago who are on a stable PD medication regimen and able to give informed consent; post-menopausal women and those with conditions preventing safe participation are excluded.
- Who can participate?
- Participants must be between 18 Years and 56 Years.
- Where is this trial located?
- This trial is recruiting at 4 locations.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 2 years.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- Everyone in this trial receives the experimental treatment. There is no placebo group.
- What procedures are involved in this trial?
- Based on the protocol, this trial involves: Wearable / at-home monitoring (non-invasive); Questionnaires & surveys (non-invasive). Confirm the full schedule with the study coordinator.